{"organizations": [], "uuid": "67766d9f85197e69fa6ad14a6bfa52dde08afad3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shanghai-fosun-pharmaceutical-grou/brief-shanghai-fosun-pharmaceutical-group-units-receive-approval-for-drug-clinical-trials-idUSL4N1PJ1RR", "country": "US", "domain_rank": 408, "title": "BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-24T11:17:00.000+02:00", "replies_count": 0, "uuid": "67766d9f85197e69fa6ad14a6bfa52dde08afad3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shanghai-fosun-pharmaceutical-grou/brief-shanghai-fosun-pharmaceutical-group-units-receive-approval-for-drug-clinical-trials-idUSL4N1PJ1RR", "ord_in_thread": 0, "title": "BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "shanghai fosun pharmaceutical group co ltd", "sentiment": "negative"}, {"name": "brief-shanghai fosun pharmaceutical group", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd\n* Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor\nSource text in Chinese: goo.gl/KA8dec\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/KA8dec", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T11:17:00.000+02:00", "crawled": "2018-01-24T15:37:53.020+02:00", "highlightTitle": ""}